What is MaxCyte's current ratio?

MaxCyte (MXCT) reported current ratio of 12× in Q1 2026.

How has MaxCyte's current ratio changed year-over-year?

MaxCyte's current ratio decreased by 1.6% year-over-year, from 12.2× to 12×.

What is the long-term trend for MaxCyte's current ratio?

Over 5 years (2020 to 2025), MaxCyte's current ratio has grown at a 16.3% compound annual growth rate (CAGR), from 3.9× to 8.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

MaxCyte MXCT Current ratio

Current ratio at other companies

Bio-Rad LaboratoriesBIO

3.2×-2.8×

Thermo Fisher ScientificTMO

1.5×-0.2×

Ginkgo BioworksDNA

5.2×+0.3×

Immix Biopharma, Inc.IMMX

8.8×+7.0×

Rapid Micro BiosystemsRPID

2.6×-2.0×

PDE

Pro-Dex, Inc.PDEX

3.7×+0.9×

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Where this comes from

Calculated from MaxCyte’s reported figures.

total current assets/total current liabilities=12×

Based on the most recent quarter.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's current ratio?: MaxCyte (MXCT) reported current ratio of 12× in Q1 2026.
How has MaxCyte's current ratio changed year-over-year?: MaxCyte's current ratio decreased by 1.6% year-over-year, from 12.2× to 12×.
What is the long-term trend for MaxCyte's current ratio?: Over 5 years (2020 to 2025), MaxCyte's current ratio has grown at a 16.3% compound annual growth rate (CAGR), from 3.9× to 8.3×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.